Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE - OncologySTAT
Links shared publicly online about this topic.
- 413total visits
Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE - OncologySTAT
J Clin Oncol. 2011 Mar 7;[Epub Ahead of Print] - S Grunberg, D Chua, A Maru, J Dinis, S Devandry, JA Boice, JS Hardwick, E Beckford, A Taylor, A Carides, F Roila, J Herrstedt
View full resource at oncologystat.com
Most Recently Shared on March 25, 2011 at 4:43 pm By:
Story of the Week With Expert Commentary: Anti-Emesis: IV Fosaprepitant Noninferior to Oral Aprepitant http://tinyurl.com/4dcqaut
Oncology Article | Nausea Vomiting Cisplatin
mdlinx.com — “Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: Randomized, double-blind study protocol--EASE” View full resource at mdlinx.com
Most Recently Shared on March 10, 2011 at 5:45 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated wi... http://bit.ly/hdZEyv #oncology
Advertisement
